Postmenopausal estradiol-progestagen therapy and risk for uterine cervical cancer

International Journal of Cancer

Volumn 131, Issue 4, 2012, Pages

  Jaakkola, Susanna ^a   Pukkala, Eero ^b   K lyytinen, Heli ^a   Ylikorkala, Olavi ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

Author keywords

adenocarcinoma; estrogen; postmenopausal hormone therapy; progestagen; squamous cell carcinoma

Indexed keywords

DYDROGESTERONE; ESTRADIOL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FINLAND; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA;

ESTRADIOL; FEMALE; FINLAND; HUMANS; INCIDENCE; MIDDLE AGED; POSTMENOPAUSE; PROGESTINS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84862535357     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27321     Document Type: Article

References (28)

1. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE,. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011; 103: 368-83.
2. Dahlström LA, Ylitalo N, Sundström K, Palmgren J, Ploner A, Eloranta, Sanjeevi CB, Andersson S, Rohan T, Dillner J, Adami H-O, Sparén P,. Prospective study of human papillomavirus and risk of cervical adenocarcinoma. Int J Cancer 2010; 127: 1923-30.
3. Hunter RE, Longscope C, Keuough P,. Steroid hormone receptors in carcinoma of the cervix. Cancer 1987: 60: 392-6. (Pubitemid 17098606)
4. Bodner K, Laubichler P, Kimberger O, Czerwenka K, Zeillinger R, Bodner-Adler B,. Oestrogen and progesterone receptor expression in patients with adenocarcinoma of the uterine cervix and correlation with various clinicopathological parameters. Anticancer Res 2010; 30: 1341-6.
5. Appleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, Goodhill A, Green J, Peto J, Plummer M, Sweetland S,. Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007; 370: 1609-21.
6. The Finnish Cancer Registry. Available at:. Accessed on May 8, 2011.
7. Parazzini F, La Vecchia C, Negri E, Franceschi S, Moroni S, Chatenoud L, Bolis G,. Case-control study of oestrogen replacement therapy and risk of cervical cancer. BMJ 1997; 315: 85-8. (Pubitemid 27285440)
8. Lacey JV, Jr, Brinton LA, Barnes WA, Gravitt PE, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Kurman RJ, Hildesheim A,. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol 2000; 77: 129-54.
9. Lyytinen H, Pukkala E, Ylikorkala O,. Breast cancer risk in postmenopausal women using estradiol-progestogen therapy. Obstet Gynecol 2009; 113: 65-73.
10. Jaakkola S, Lyytinen HK, Dyba Tadeusz, Ylikorkala O, Pukkala E,: Endometrial cancer associated with various forms of postmenopausal hormone therapy: a case control study. Int J Cancer 2011; 128: 1644-51.
11. Jaakkola S, Lyytinen H, Pukkala E, Ylikorkala O,. Nationwide study on endometrial cancer in postmenopausal women using estradiol-progestagen therapy. Obstet Gynecol 2009; 114: 1197-204.
12. Teppo L, Pukkala E, Lehtonen M,. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994; 33: 365-9. (Pubitemid 24207996)
13. Keskimaki I, Aro S, Teperi J,. Regional variation in surgical procedure rates in Finland. Scand J Soc Med 1994; 22: 132-8. (Pubitemid 24191574)
14. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Jr, Young N,. The 2001 Bethesda System. Terminology for reporting Results of cervical Cytology. JAMA 2002; 287: 2114-19. (Pubitemid 34437346)
15. International Classification of Diseases for Oncology, 3rd edn. Geneva: World Health Organization, 2000.
16. Rothman KJ, Greenland S,. Modern Epidemiology, 2nd edn. Philadelphia, PA: Lippincott-Raven Publishers, 1998.
17. Luoto R, Raitanen J, Pukkala E, Anttila A,. Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953-2010. Br J Cancer 2004; 90: 1756-9. (Pubitemid 38725647)
18. Lacey JV, Jr, Swanson CA, Brinton LA, Altekruse SF, Barnes WA, Gravitt PE, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Kurman RJ, et al. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix. Cancer 2003; 98: 814-21. (Pubitemid 36959279)
19. Appleby P, Beral V, Berrington de González A, Colin D, Franceschi S, Green J, Peto J, Plummer M, Sweetland S,. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 2006; 120: 885-91.
20. Topo P, Luoto R, Hemminki E, Uutela A,. Declining socioeconomic differences in the use of menopausal and postmenopausal hormone therapy in Finland. Maturitas 1999; 32: 141-5. (Pubitemid 29389728)
21. Yasmeen S, Romano PS, Pettinger M, Johnson SR, Hubbell FA, Lane DS, Hendrix SL,. Incidence of cervical cytological abnormalities with aging in the women's health initiative. Obstet Gynecol 2006; 108: 410-9. (Pubitemid 44305684)
22. Sawaya GF, Grady D, Kerlikwske K, La Valleur J, barnabei VM, Bass K, Snyder TE, Picar JH, Agarwal SK, Mandelblatt J,. The positive predictive value of cervical smears in previously screened postmenopausal women: The heart and estrogen/progestagen replacement study (HERS). Ann Intern Med 2000; 133: 942-50. (Pubitemid 32003510)
23. Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Moller H, Hakama M, Parkin DM,. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005; 14: 677-86. (Pubitemid 40489214)
24. Pukkala E, Malila N, Hakama M,. Socioeconomic differences in incidence of cervical cancer in Finland by cell type. Acta Oncol 2010; 49: 180-4.
25. Cardozo L, Bachmann G, McClish D, Fonda D, Birgerson L,. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: Second report of the hormones and urogenital therapy committee. Obstet Gynecol 1998; 92: 722-7. (Pubitemid 28440818)
26. Bray F, Carstensen B, Moller H, Zappa M, Zakelj MP, Lawrence G, Hakama M, Weiderpass E,. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005; 14: 2191-9. (Pubitemid 41603267)
27. Gunnell AS, Ylitalo N, Sandin S, Sparen P, Adami HO, Ripatti S,. Longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment. Cancer Epidemiol Biomarkers Prev 2007; 16: 2641-8. (Pubitemid 351196320)
28. Sasieni P, Castanon A, Cuzick J,. Screening and adenocarcinoma of the cervix. Int J Cancer 2009; 125: 525-9.